Astrazeneca and Gilead are not currently in deal talks, sources tell CNBC

CNBC's David Faber reports Astrazeneca and Gilead may have been a "CEO to CEO approach" regarding potential deal talks, but there does not appear to be any ongoing discussions at the moment.
Mon, Jun 8 20209:33 AM EDT